On May 27, 2025, analyst Jason Butler from JMP Securities announced an adjustment to the stock target price for Prothena Corp (PRTA, Financial). The target price has been lowered from a previous $78.00 USD to a new target of $29.00 USD. This marks a significant reduction of 62.82% in the stock's target price.
Despite this substantial change in the projected target, the analyst has maintained their "Market Outperform" rating for Prothena Corp (PRTA, Financial). This consistent rating indicates that the stock is still expected to perform better than the overall market, according to JMP Securities.
Prothena Corp (PRTA, Financial) is listed on the NASDAQ exchange. It is important for investors to keep track of these updates as analyst ratings and target price adjustments can significantly impact stock performance and investment decisions.
Wall Street Analysts Forecast
Based on the one-year price targets offered by 8 analysts, the average target price for Prothena Corp PLC (PRTA, Financial) is $36.00 with a high estimate of $81.00 and a low estimate of $6.00. The average target implies an upside of 447.11% from the current price of $6.58. More detailed estimate data can be found on the Prothena Corp PLC (PRTA) Forecast page.
Based on the consensus recommendation from 10 brokerage firms, Prothena Corp PLC's (PRTA, Financial) average brokerage recommendation is currently 2.4, indicating "Outperform" status. The rating scale ranges from 1 to 5, where 1 signifies Strong Buy, and 5 denotes Sell.
Based on GuruFocus estimates, the estimated GF Value for Prothena Corp PLC (PRTA, Financial) in one year is $28.79, suggesting a upside of 337.54% from the current price of $6.58. GF Value is GuruFocus' estimate of the fair value that the stock should be traded at. It is calculated based on the historical multiples the stock has traded at previously, as well as past business growth and the future estimates of the business' performance. More detailed data can be found on the Prothena Corp PLC (PRTA) Summary page.
